MedTrace Logo

Effect of Addition of Steroids on Duration of Analgesia

NCT04126824 · Status: ACTIVE_NOT_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2025-12-17

No results posted yet for this study

Summary

The purpose of the study is to investigate the differences in post-procedural pain scores and narcotic use among patients who receive a Superior Hypogastric Nerve Block (SHNB) with and without corticosteroid performed as part of the Uterine Artery Embolization (UAE) procedure.

Conditions

  • Uterine Fibroids
  • Adenomyosis

Interventions

DRUG

Triamcinolone

40 mg triamcinolone administered as a Superior Hypogastric Nerve Block (SHNB)

DRUG

Bupivacaine

0.5% bupivacaine (20 mL) administered as a Superior Hypogastric Nerve Block (SHNB).

OTHER

Iohexol contrast

The appropriate amount of contrast to enable visualization of the nerve block under fluoroscopy given as a Superior Hypogastric Nerve Block (SHNB) will be administered.

Sponsors & Collaborators

Principal Investigators

  • Jessica K Stewart, MD · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-06
Primary Completion
2026-08-02
Completion
2027-08-02
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04126824 on ClinicalTrials.gov